Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals for Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals for Therapeutic. This report contains market size and forecasts of Radiopharmaceuticals for Therapeutic in global, including the following market information:
Global Radiopharmaceuticals for Therapeutic Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Radiopharmaceuticals for Therapeutic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Radium-223 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Radiopharmaceuticals for Therapeutic include Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Lantheus and Spectrum Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radiopharmaceuticals for Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiopharmaceuticals for Therapeutic Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Radiopharmaceuticals for Therapeutic Market Segment Percentages, by Type, 2022 (%)
Radium-223
Lutetium-177
Iodine-131
Other
Global Radiopharmaceuticals for Therapeutic Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Radiopharmaceuticals for Therapeutic Market Segment Percentages, by Application, 2022 (%)
Thyroid
Bone Metastasis
Lymphoma
Other
Global Radiopharmaceuticals for Therapeutic Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Radiopharmaceuticals for Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceuticals for Therapeutic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Radiopharmaceuticals for Therapeutic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radiopharmaceuticals for Therapeutic, market overview.
Chapter 2: Global Radiopharmaceuticals for Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Radiopharmaceuticals for Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiopharmaceuticals for Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals for Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceuticals for Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceuticals for Therapeutic Overall Market Size
2.1 Global Radiopharmaceuticals for Therapeutic Market Size: 2022 VS 2030
2.2 Global Radiopharmaceuticals for Therapeutic Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radiopharmaceuticals for Therapeutic Players in Global Market
3.2 Top Global Radiopharmaceuticals for Therapeutic Companies Ranked by Revenue
3.3 Global Radiopharmaceuticals for Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Radiopharmaceuticals for Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Radiopharmaceuticals for Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals for Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Radiopharmaceuticals for Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Radiopharmaceuticals for Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Radiopharmaceuticals for Therapeutic Market Size Markets, 2022 & 2030
4.1.2 Radium-223
4.1.3 Lutetium-177
4.1.4 Iodine-131
4.1.5 Other
4.2 By Type - Global Radiopharmaceuticals for Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceuticals for Therapeutic Revenue, 2018-2023
4.2.2 By Type - Global Radiopharmaceuticals for Therapeutic Revenue, 2024-2030
4.2.3 By Type - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radiopharmaceuticals for Therapeutic Market Size, 2022 & 2030
5.1.2 Thyroid
5.1.3 Bone Metastasis
5.1.4 Lymphoma
5.1.5 Other
5.2 By Application - Global Radiopharmaceuticals for Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceuticals for Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global Radiopharmaceuticals for Therapeutic Revenue, 2024-2030
5.2.3 By Application - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Radiopharmaceuticals for Therapeutic Market Size, 2022 & 2030
6.2 By Region - Global Radiopharmaceuticals for Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceuticals for Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global Radiopharmaceuticals for Therapeutic Revenue, 2024-2030
6.2.3 By Region - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.3.2 US Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.3.3 Canada Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.3.4 Mexico Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.4.2 Germany Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.3 France Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.4 U.K. Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.5 Italy Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.6 Russia Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.7 Nordic Countries Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.4.8 Benelux Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.5.2 China Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5.3 Japan Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5.4 South Korea Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5.5 Southeast Asia Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.5.6 India Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.6.2 Brazil Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.6.3 Argentina Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radiopharmaceuticals for Therapeutic Revenue, 2018-2030
6.7.2 Turkey Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.7.3 Israel Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.7.4 Saudi Arabia Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
6.7.5 UAE Radiopharmaceuticals for Therapeutic Market Size, 2018-2030
7 Radiopharmaceuticals for Therapeutic Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Radiopharmaceuticals for Therapeutic Major Product Offerings
7.1.4 Bayer Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Radiopharmaceuticals for Therapeutic Major Product Offerings
7.2.4 Novartis Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 China Isotope & Radiation
7.3.1 China Isotope & Radiation Company Summary
7.3.2 China Isotope & Radiation Business Overview
7.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Major Product Offerings
7.3.4 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.3.5 China Isotope & Radiation Key News & Latest Developments
7.4 Dongcheng
7.4.1 Dongcheng Company Summary
7.4.2 Dongcheng Business Overview
7.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Major Product Offerings
7.4.4 Dongcheng Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.4.5 Dongcheng Key News & Latest Developments
7.5 Q BioMed
7.5.1 Q BioMed Company Summary
7.5.2 Q BioMed Business Overview
7.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Major Product Offerings
7.5.4 Q BioMed Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.5.5 Q BioMed Key News & Latest Developments
7.6 Curium Pharmaceuticals
7.6.1 Curium Pharmaceuticals Company Summary
7.6.2 Curium Pharmaceuticals Business Overview
7.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Major Product Offerings
7.6.4 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Curium Pharmaceuticals Key News & Latest Developments
7.7 Jubilant DraxImage
7.7.1 Jubilant DraxImage Company Summary
7.7.2 Jubilant DraxImage Business Overview
7.7.3 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Major Product Offerings
7.7.4 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.7.5 Jubilant DraxImage Key News & Latest Developments
7.8 Lantheus
7.8.1 Lantheus Company Summary
7.8.2 Lantheus Business Overview
7.8.3 Lantheus Radiopharmaceuticals for Therapeutic Major Product Offerings
7.8.4 Lantheus Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.8.5 Lantheus Key News & Latest Developments
7.9 Spectrum Pharmaceuticals
7.9.1 Spectrum Pharmaceuticals Company Summary
7.9.2 Spectrum Pharmaceuticals Business Overview
7.9.3 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Major Product Offerings
7.9.4 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.9.5 Spectrum Pharmaceuticals Key News & Latest Developments
7.10 Progenics Pharmaceuticals
7.10.1 Progenics Pharmaceuticals Company Summary
7.10.2 Progenics Pharmaceuticals Business Overview
7.10.3 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Major Product Offerings
7.10.4 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.10.5 Progenics Pharmaceuticals Key News & Latest Developments
7.11 International Isotopes
7.11.1 International Isotopes Company Summary
7.11.2 International Isotopes Business Overview
7.11.3 International Isotopes Radiopharmaceuticals for Therapeutic Major Product Offerings
7.11.4 International Isotopes Radiopharmaceuticals for Therapeutic Revenue in Global Market (2018-2023)
7.11.5 International Isotopes Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Radiopharmaceuticals for Therapeutic Market Opportunities & Trends in Global Market
Table 2. Radiopharmaceuticals for Therapeutic Market Drivers in Global Market
Table 3. Radiopharmaceuticals for Therapeutic Market Restraints in Global Market
Table 4. Key Players of Radiopharmaceuticals for Therapeutic in Global Market
Table 5. Top Radiopharmaceuticals for Therapeutic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Radiopharmaceuticals for Therapeutic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Radiopharmaceuticals for Therapeutic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Radiopharmaceuticals for Therapeutic Product Type
Table 9. List of Global Tier 1 Radiopharmaceuticals for Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceuticals for Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Radiopharmaceuticals for Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Radiopharmaceuticals for Therapeutic Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Radiopharmaceuticals for Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Radiopharmaceuticals for Therapeutic Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Radiopharmaceuticals for Therapeutic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Radiopharmaceuticals for Therapeutic Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2024-2030
Table 30. Bayer Company Summary
Table 31. Bayer Radiopharmaceuticals for Therapeutic Product Offerings
Table 32. Bayer Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Radiopharmaceuticals for Therapeutic Product Offerings
Table 36. Novartis Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. China Isotope & Radiation Company Summary
Table 39. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product Offerings
Table 40. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 41. China Isotope & Radiation Key News & Latest Developments
Table 42. Dongcheng Company Summary
Table 43. Dongcheng Radiopharmaceuticals for Therapeutic Product Offerings
Table 44. Dongcheng Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 45. Dongcheng Key News & Latest Developments
Table 46. Q BioMed Company Summary
Table 47. Q BioMed Radiopharmaceuticals for Therapeutic Product Offerings
Table 48. Q BioMed Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 49. Q BioMed Key News & Latest Developments
Table 50. Curium Pharmaceuticals Company Summary
Table 51. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offerings
Table 52. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 53. Curium Pharmaceuticals Key News & Latest Developments
Table 54. Jubilant DraxImage Company Summary
Table 55. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product Offerings
Table 56. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 57. Jubilant DraxImage Key News & Latest Developments
Table 58. Lantheus Company Summary
Table 59. Lantheus Radiopharmaceuticals for Therapeutic Product Offerings
Table 60. Lantheus Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 61. Lantheus Key News & Latest Developments
Table 62. Spectrum Pharmaceuticals Company Summary
Table 63. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offerings
Table 64. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 65. Spectrum Pharmaceuticals Key News & Latest Developments
Table 66. Progenics Pharmaceuticals Company Summary
Table 67. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offerings
Table 68. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 69. Progenics Pharmaceuticals Key News & Latest Developments
Table 70. International Isotopes Company Summary
Table 71. International Isotopes Radiopharmaceuticals for Therapeutic Product Offerings
Table 72. International Isotopes Radiopharmaceuticals for Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 73. International Isotopes Key News & Latest Developments
List of Figures
Figure 1. Radiopharmaceuticals for Therapeutic Segment by Type in 2022
Figure 2. Radiopharmaceuticals for Therapeutic Segment by Application in 2022
Figure 3. Global Radiopharmaceuticals for Therapeutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Radiopharmaceuticals for Therapeutic Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Radiopharmaceuticals for Therapeutic Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radiopharmaceuticals for Therapeutic Revenue in 2022
Figure 8. By Type - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 9. By Application - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 10. By Type - Global Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 12. By Application - Global Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 14. By Region - Global Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 15. By Country - North America Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 16. US Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 20. Germany Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 21. France Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 28. China Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 32. India Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 34. Brazil Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Radiopharmaceuticals for Therapeutic Revenue Market Share, 2018-2030
Figure 37. Turkey Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Radiopharmaceuticals for Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 41. Bayer Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dongcheng Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Q BioMed Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lantheus Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. International Isotopes Radiopharmaceuticals for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
